![\"Gubatan](\"https:\/\/cdn.sci.news\/images\/enlarge13\/image_14652e-Inflammatory-Bowel-Disease.jpg\")
<\/a><\/p>\nGubatan et al. demonstrate that vitamin D promotes immune tolerance to gut microbiota in patients with inflammatory bowel disease. Image credit: Gubatan et al., doi: 10.1016\/j.xcrm.2026.102703.<\/p>\n
Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is a chronic inflammatory disorder of the gastrointestinal tract that is thought to arise from a complex interplay between host genetic predisposition1 and environmental triggers.<\/p>\n
Loss of immune tolerance to commensal gut bacteria has been recognized to play a pivotal role in the pathogenesis of IBD.<\/p>\n
Current therapeutic strategies in IBD have focused mainly on targeting dysregulated immune responses without directly addressing gut microbiome crosstalk with intestinal immunity.<\/p>\n
Understanding the mechanisms that regulate host immune-microbe interactions and developing ways to restore immune tolerance to gut microbiota could lead to therapeutic strategies to treat or prevent IBD.<\/p>\n
\u201cThis study suggests vitamin D may help rebalance how the immune system sees gut bacteria,\u201d said Dr. John Mark Gubatan, a gastroenterologist at Mayo Clinic.<\/p>\n
\u201cThat\u2019s an important step toward understanding how we might restore immune tolerance in IBD.\u201d<\/p>\n
In the new study, the researchers evaluated 48 people with IBD who had low vitamin D levels.<\/p>\n
Participants received weekly vitamin D supplements for 12 weeks. Blood and stool samples collected before and after treatment were analyzed using advanced sequencing to map interactions between immune responses and the gut microbiome.<\/p>\n
Vitamin D supplementation was associated with increased levels of immunoglobulin A (IgA), which is typically linked to protective immune responses, and decreased levels of immunoglobulin G (IgG), more often associated with inflammation.<\/p>\n
The scientists also observed changes in immune signaling pathways and increased activity of regulatory immune cells that help control inflammation.<\/p>\n
Together, these findings suggest vitamin D may help promote a more balanced, protective immune response to the gut microbiome.<\/p>\n
Vitamin D supplementation was also associated with improvements in disease activity scores and a stool-based marker of inflammation.<\/p>\n
However, the authors emphasize the study was small and not designed to establish cause and effect.<\/p>\n
\u201cWe saw encouraging signals, but this was not a randomized trial,\u201d Dr. Gubatan said.<\/p>\n
\u201cThese findings need to be confirmed in larger, controlled studies.\u201d<\/p>\n
The researchers caution that patients should not change their vitamin D use without medical guidance.<\/p>\n
\u201cVitamin D is widely available, but dosing needs to be individualized, especially in patients with chronic inflammation. Patients should work with their healthcare team,\u201d Dr. Gubatan concluded.<\/p>\n